Q2 2025 Holdings
Filed 2025-08-14 | 63 holdings | $1.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Natera Inc(NTRA) | COM | 632307104 | $261.9M | 1,550,280 | 16.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $116.4M | 1,050,308 | 7.1% |
| Eli Lilly and Co(LLY) | COM | 532457108 | $75.6M | 97,018 | 4.6% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $73.7M | 694,096 | 4.5% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $65.8M | 2,793,987 | 4.0% |
| iShares TR(IWM)Put | RUSSELL 2000 ETF | 464287655 | $53.9M | 250,000 | 3.3% |
| AbbVie Inc(ABBV) | COM | 00287Y109 | $49.3M | 265,850 | 3.0% |
| iShares TR(IBB)Put | ISHARES BIOTECH | 464287556 | $47.4M | 375,000 | 2.9% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $46.3M | 431,200 | 2.8% |
| Dexcom Inc(DXCM) | COM | 252131107 | $45.7M | 523,694 | 2.8% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $45.1M | 2,147,795 | 2.8% |
| BridgeBio Pharma Inc(BBIO) | COM | 10806X102 | $42.9M | 993,093 | 2.6% |
| Intuitive Surgical Inc(ISRG) | COM | 46120E602 | $38.4M | 70,642 | 2.3% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $37.0M | 586,010 | 2.3% |
| Arrivent BioPharma Inc(AVBP) | COM | 04272N102 | $36.9M | 1,696,752 | 2.3% |
| Roivant Sciences Ltd(ROIV) | SHS | G76279101 | $34.8M | 3,088,814 | 2.1% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $34.8M | 415,219 | 2.1% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $34.1M | 118,513 | 2.1% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $31.6M | 313,923 | 1.9% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $29.3M | 548,788 | 1.8% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $25.2M | 799,253 | 1.5% |
| AnaptysBio Inc(ANAB) | COM | 032724106 | $22.9M | 1,032,362 | 1.4% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $22.7M | 1,995,594 | 1.4% |
| Uniqure NV(QURE) | SHS | N90064101 | $21.7M | 1,558,356 | 1.3% |
| Merus N V | COM | N5749R100 | $21.3M | 404,562 | 1.3% |
| AstraZeneca PLC(AZN) | SPONSORED ADR | 046353108 | $20.5M | 293,661 | 1.3% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $18.4M | 375,939 | 1.1% |
| Inozyme Pharma Inc | COM | 45790W108 | $17.1M | 4,280,308 | 1.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $16.9M | 2,355,505 | 1.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $16.8M | 1,806,529 | 1.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $16.6M | 584,801 | 1.0% |
| Summit Therapeutics Inc(SMMT)Call | COM | 86627T108 | $14.9M | 700,000 | 0.9% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $14.3M | 1,524,440 | 0.9% |
| Rhythm Pharmaceuticals Inc(RYTM)Put | COM | 76243J105 | $14.2M | 225,000 | 0.9% |
| Replimune Group Inc(REPL)Put | COM | 76029N106 | $13.9M | 1,500,000 | 0.9% |
| Cidara Therapeutics Inc(CDTX) | COM | 171757206 | $12.2M | 251,031 | 0.7% |
| Immatics N.v(IMTX) | SHS | N44445109 | $12.1M | 2,240,528 | 0.7% |
| Roivant Sciences Ltd(ROIV)Call | SHS | G76279101 | $11.3M | 1,000,000 | 0.7% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $11.1M | 208,300 | 0.7% |
| Pharvaris N V(PHVS) | COM | N69605108 | $10.3M | 585,532 | 0.6% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $10.1M | 708,678 | 0.6% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $9.9M | 1,216,016 | 0.6% |
| Y-mAbs Therapeutics Inc(YMABUSD) | COM | 984241109 | $9.9M | 2,194,278 | 0.6% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $9.8M | 93,610 | 0.6% |
| BioAge Labs Inc(BIOA) | COM | 09077V100 | $9.5M | 2,304,901 | 0.6% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $9.4M | 716,873 | 0.6% |
| Immunome Inc(IMNM) | COM | 45257U108 | $7.2M | 778,476 | 0.4% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $5.9M | 614,865 | 0.4% |
| Savara Inc(SVRA) | COM | 805111101 | $5.6M | 2,457,352 | 0.3% |
| Cidara Therapeutics Inc(CDTX)Call | COM | 171757206 | $4.9M | 100,000 | 0.3% |